Pfeffer, M.A. et al. (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. New England Journal of Medicine, 361(21), pp. 2019-2032. (doi: 10.1056/NEJMoa0907845)
Full text not currently available from Enlighten.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Cooper, Dr Mark and McMurray, Professor John |
Authors: | Pfeffer, M.A., Burdmann, E.A., Chen, C.Y., Cooper, M.A., Cooper, M.J., de Zeeuw, D., Eckardt, K.U., Feyzi, J.M., Ivanovich, P., Kewalramani, R., Levey, A.S., Lewis, E.F., Mcgill, J.B., McMurray, J.J., Parfrey, P., Parving, H.H., Remuzzi, G., Singh, A.K., Solomon, S.D., and Toto, R. |
College/School: | College of Medical Veterinary and Life Sciences College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
Journal Name: | New England Journal of Medicine |
Publisher: | Massachusetts Medical Society |
ISSN: | 0028-4793 |
ISSN (Online): | 1533-4406 |
University Staff: Request a correction | Enlighten Editors: Update this record